• Investing in health
    Focusing on medical innovation
    INVESTING IN
    HEALTH
  • Pharma Biotech Funds
    opportunities with breakthrough potential
    The technologies
    of tomorrow
  • Ethical, Sustainable, Responsible and Green investmens
    driven by high ethical values
    Responsible investments
    for people who care

Pharma & Biotech

We invest in companies that have potential breakthrough treatments with promising data and a reasonable Proof of Concept of efficacy and safety.



MedTech

We invest in medical device companies developing novel products and technologies with the potential to change the landscape in their areas.



Environment Protection

We may also selectively make investments in companies with technologies that have the potential for an impact on helping the environment.


Pharmaceuticals biotech medtech green funds
Who we are and what we do

Investing in Health

We are a healthcare investment company based in in Zurich, Switzerland, supported by prestigious research advisors and organizations.

Our proprietary approach is based on sourcing of novel opportunities with the potential to be breakthroughs in their own areas, structuring investment on a case by case basis, supporting the portfolio companies and facilitating corporate deals. We invest primarily in the life sciences (Pharma, Biotech, MedTech) with a particular focus on safe and efficacious treatments for serious diseases.

We are devoted to addressing unmet medical needs through financing the development of novel products and technologies that can help alleviate human suffering from disease, while supporting the environment.




FOCUSED, FLEXIBLE, SUPPORTIVE, CREATIVE

WHAT MAKES US DIFFERENT: Traditional investors are geared towards simple equity investments, and whereas they can attach special rights to their shares, the effect is that they are dependent on selling the shares in order to provide return to their own investors.
We are not a fund, but an investment company. We structure investments to fit each particular opportunity to facilitate faster crystallisation of value for our shareholders while supporting each portfolio company to deliver the much needed solutions for human health.